Inventor · disambiguated record
Bryan Mckibben
Also filed as: MCKIBBEN BRYAN · MCKIBBEN BRYAN P · MCKIBBEN BRYAN PATRICK
25 granted patents·11 pending applications·459 citations·filing 1997–2020
96Inventor score
Files withOSI PHARM INC18BOEHRINGER INGELHEIM INT11BALESTRA MICHAEL1BARBOSA ANTONIO J M1BARBOSA JR ANTONIO JOSE DEL MORAL1
Top patents by PatentIndex Score
36 records- 0195US6680324B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 20, 2004·68 cites·37 claims
- 0295US6680322B2Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 20, 2004·67 cites·37 claims
- 0392US7601714B2Pyrimidine derivatives useful as inhibitors of PKC-thetaBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Oct 13, 2009·33 cites·9 claims
- 0492US6916804B2Pyrimidine A2b selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2002·Granted Jul 12, 2005·45 cites·22 claims
- 0589US6800633B2Pyrrolo[2,3d]pyrimidine compositions and their useOSI PHARM INC·Filed 2000·Granted Oct 5, 2004·29 cites·16 claims
- 0689US6673802B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2001·Granted Jan 6, 2004·26 cites·16 claims
- 0788US7504407B2Compounds specific to adenosine A1 and A3 receptors and uses thereofOSI PHARM INC·Filed 2002·Granted Mar 17, 2009·29 cites·12 claims
- 0886US9975882B2Heteroaromatic compounds as BTK inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted May 22, 2018·5 cites·40 claims
- 0986US6664252B24-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Dec 16, 2003·28 cites·34 claims
- 1085US7160890B2Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 2000·Granted Jan 9, 2007·16 cites·46 claims
- 1183US7429574B24-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their useOSI PHARM INC·Filed 2004·Granted Sep 30, 2008·14 cites·8 claims
- 1281US6878716B1Compounds specific to adenosine A1 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Apr 12, 2005·27 cites·35 claims
- 1379US9334285B2Aldosterone synthase inhibitorsBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 10, 2016·5 cites·42 claims
- 1479US9181272B2Aldosterone synthase inhibitorsBALESTRA MICHAEL·Filed 2014·Granted Nov 10, 2015·8 cites·16 claims
- 1579US7572921B2Substituted benzylimidazoles useful for the treatment of inflammatory diseasesBOEHRINGER INGELHEIM INT·Filed 2006·Granted Aug 11, 2009·4 cites·6 claims
- 1676US7501407B2Pyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2004·Granted Mar 10, 2009·8 cites·7 claims
- 1773US7645754B2Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and useOSI PHARM INC·Filed 2007·Granted Jan 12, 2010·1 cites·10 claims
- 1873US7598252B2Compounds specific to adenosine A, receptors and uses thereofOSI PHARM INC·Filed 2003·Granted Oct 6, 2009·4 cites·6 claims
- 1969US6686366B1Compounds specific to adenosine A3 receptor and uses thereofOSI PHARM INC·Filed 1999·Granted Feb 3, 2004·32 cites·50 claims
- 2069US2021009567A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2165US2020055843A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 2263US8552205B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amidesBARBOSA JR ANTONIO JOSE DEL MORAL·Filed 2008·Granted Oct 8, 2013·1 cites·49 claims
- 2363US2019092759A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2462US2018222893A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2562US2009082369A1Pyrrolo[2,3d]pyrimidine compositions and their useOSI PHARM INC·Filed 2008·Application pending·0 cites
- 2660US2018030037A1Heteroaromatic compounds as btk inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2760US2008070936A1Compounds specific to adenosine A1 receptors and uses thereofOSI PHARM INC·Filed 2007·Application pending·0 cites
- 2859US6037340ASynthesis and use of thiophene- and pyrrole-based heteroaromatic compoundsOSI PHARM·Filed 1997·Granted Mar 14, 2000·9 cites·64 claims
- 2958US2009192177A12-ARYL pyrrologpyrimidines for A1 and A3 receptorsOSI PHARM INC·Filed 2008·Application pending·0 cites
- 3053US2008287410A1Pyrimidine derivatives useful as inhibitors of pkc-thetaBARBOSA ANTONIO J M·Filed 2008·Application pending·0 cites
- 3149US2003229067A1Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and useFiled 2002·Application pending·0 cites
- 3244US9533999B2Fused thiazin-3-ones as KCA3.1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2013·Granted Jan 3, 2017·0 cites·28 claims
- 3342US10858342B2Bicyclic imidazole derivatives useful for the treatment of renal diseases, cardiovascular diseases and fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Dec 8, 2020·0 cites·11 claims
- 3441US2003139427A1Bicyclic pyrimidinyl derivatives and methods of use thereofOSI PHARM INC·Filed 2002·Application pending·0 cites
- 3539US10138222B2Substituted benzamides as RIPK2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Nov 27, 2018·0 cites·33 claims
- 3627US8575360B2Derivatives of 6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carboxylic acid amidesLEMIEUX RENE MARC·Filed 2010·Granted Nov 5, 2013·0 cites·34 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →